Green NK - Search Results

1

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.

Fisher KD, Stallwood Y, Green NK, Ulbrich K, Mautner V, Seymour LW. Fisher KD, et al. Among authors: green nk. Gene Ther. 2001 Mar;8(5):341-8. doi: 10.1038/sj.gt.3301389. Gene Ther. 2001. PMID: 11313809

2

Adenovirus type 5 interactions with human blood cells may compromise systemic delivery.

Lyons M, Onion D, Green NK, Aslan K, Rajaratnam R, Bazan-Peregrino M, Phipps S, Hale S, Mautner V, Seymour LW, Fisher KD. Lyons M, et al. Among authors: green nk. Mol Ther. 2006 Jul;14(1):118-28. doi: 10.1016/j.ymthe.2006.01.003. Epub 2006 Mar 31. Mol Ther. 2006. PMID: 16580883 Free article.

3

Chick embryo lethal orphan virus can be polymer-coated and retargeted to infect mammalian cells.

Stevenson M, Boos E, Herbert C, Hale A, Green N, Lyons M, Chandler L, Ulbrich K, van Rooijen N, Mautner V, Fisher K, Seymour L. Stevenson M, et al. Gene Ther. 2006 Feb;13(4):356-68. doi: 10.1038/sj.gt.3302655. Gene Ther. 2006. PMID: 16355117

4

Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954.

McNeish IA, Green NK, Gilligan MG, Ford MJ, Mautner V, Young LS, Kerr DJ, Searle PF. McNeish IA, et al. Among authors: green nk. Gene Ther. 1998 Aug;5(8):1061-9. doi: 10.1038/sj.gt.3300744. Gene Ther. 1998. PMID: 10326029

5

In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.

Chung-Faye GA, Chen MJ, Green NK, Burton A, Anderson D, Mautner V, Searle PF, Kerr DJ. Chung-Faye GA, et al. Among authors: green nk. Gene Ther. 2001 Oct;8(20):1547-54. doi: 10.1038/sj.gt.3301557. Gene Ther. 2001. PMID: 11704815

6

Adenovirus retargeting and systemic delivery.

Seymour LW, Fisher KD, Green NK, Hale SJ, Lyons M, Mautner V, Nicum S, Onion D, Oupicky D, Stevenson M, Ulbrich K. Seymour LW, et al. Among authors: green nk. Ernst Schering Res Found Workshop. 2003;(43):107-14. doi: 10.1007/978-3-662-05352-2_8. Ernst Schering Res Found Workshop. 2003. PMID: 12894454 Review. No abstract available.

7

Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector.

Chen MJ, Green NK, Reynolds GM, Flavell JR, Mautner V, Kerr DJ, Young LS, Searle PF. Chen MJ, et al. Among authors: green nk. Gene Ther. 2004 Jul;11(14):1126-36. doi: 10.1038/sj.gt.3302271. Gene Ther. 2004. PMID: 15164095

8

Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus.

Green NK, Herbert CW, Hale SJ, Hale AB, Mautner V, Harkins R, Hermiston T, Ulbrich K, Fisher KD, Seymour LW. Green NK, et al. Gene Ther. 2004 Aug;11(16):1256-63. doi: 10.1038/sj.gt.3302295. Gene Ther. 2004. PMID: 15215884

9

Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNA.

Carlisle RC, Briggs SS, Hale AB, Green NK, Fisher KD, Etrych T, Ulbrich K, Mautner V, Seymour LW. Carlisle RC, et al. Among authors: green nk. Gene Ther. 2006 Nov;13(22):1579-86. doi: 10.1038/sj.gt.3302814. Epub 2006 Jun 29. Gene Ther. 2006. PMID: 16810196

10

Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via alpha6-integrins.

Stevenson M, Hale AB, Hale SJ, Green NK, Black G, Fisher KD, Ulbrich K, Fabra A, Seymour LW. Stevenson M, et al. Among authors: green nk. Cancer Gene Ther. 2007 Apr;14(4):335-45. doi: 10.1038/sj.cgt.7701022. Epub 2007 Jan 19. Cancer Gene Ther. 2007. PMID: 17235355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters